DIASTOLIC FUNCTION ASSOC W/ WHOLE-BODY PALMITATE OXIDATION, SERUM HDL IN HIV+

HIV 中的舒张功能关联与全身棕榈酸氧化、血清 HDL

基本信息

  • 批准号:
    7721458
  • 负责人:
  • 金额:
    $ 0.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2009-01-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objectives: HIV and protease inhibitor (PI)-based ART are associated with abnormal lipid metabolism and diastolic dysfunction. We used submaximal exercise to stimulate whole-body lipolysis and free fatty acid (FFA) oxidation and examined relationships among FFA kinetics, resting cardiac function, and PI use in HIV+ taking PI (ritonavir¿)-based ART (HIV+PI), HIV+ taking NRTI-based ART (HIVnoPI), and HIV-negative controls (Ctrl). We hypothesized that HIV+PI would have higher lipolytic rates and lower FFA oxidation rates during rest and exercise than HIVnoPI and Ctrl, and that FFA kinetics would be associated with abnormalities in cardiac function. Methods. 1-13C palmitate was infused during rest and 70min of submaximal exercise (50% peakVO2) to quantify basal and exercise-stimulated lipolytic rate (PalmRa) and palmitate oxidation rate (PalmOx) in 3 groups: HIV+PI (n=10), HIVnoPI (n=9), and Ctrl (n=5). Resting 2-D and Doppler echocardiography was used to quantify cardiac contractile and anatomic parameters. Results: In contrast to our hypothesis, PalmRa was similar among the 3 groups during rest and exercise. Resting PalmOx was higher in HIV+PI (1.0 ¿ 0.5, p<0.05) than Ctrl (0.4 ¿ 0.1), but was not different between Ctrl and HIVnoPI (0.8 ¿ 0.4 mmol/kgFFM/min). When HIV+ groups were combined, PalmOx during rest (0.9 ¿ 0.4 vs. 0.4 ¿ 0.1) and during exercise (2.0 ¿ 0.9 vs. 0.8 ¿ 0.4 mmol/kgFFM/min, p<0.03) were higher than Ctrl. HIV+ subjects exhibited lower early diastolic velocity (global em: 12.0 ¿ 4.0 vs. 16.4 ¿ 3.8 m/s, p<0.02) and peak early (E) to peak late (A) diastolic flow velocity ratio (E/A ratio: 1.4 ¿ 0.4 vs. 2.1 ¿ 0.5, p<0.001) while left ventricular mass index (LVMI) tended to be greater (97.1 ¿ 14.4 vs. 86.1 ¿ 6.2 g/m2, p<0.09) than Ctrl. PalmOx during exercise was related to LVMI (r=0.46, p<0.05). Serum high-density lipoprotein (HDL) levels were positively related to global em (r=0.58, p<0.003), ejection fraction (r=0.37, p<0.08), flow propagation (r=0.56, p<0.006), E (r=0.44, p<0.03), E/A (r=0.55, p<0.006) and negatively related to mean arterial pressure (r= - 0.49, p<0.02) and diastolic BP (r= - 0.49, p<0.02). Conclusion: HIV infection regardless of PI use was associated with elevated whole-body FFA oxidation rates during rest and exercise. Elevated FFA oxidation and lower serum HDL levels were predictive of depressed cardiac, specifically diastolic, function.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 目的:HIV和蛋白酶抑制剂(PI)为基础的ART与脂质代谢异常和舒张功能障碍有关。我们使用次极量运动刺激全身脂肪分解和游离脂肪酸(FFA)氧化,并在HIV+服用PI(利托那韦)的ART(HIV+PI)、HIV+服用NRTI的ART(HIVnoPI)和HIV阴性对照(Ctrl)中检查FFA动力学、静息心脏功能和PI使用之间的关系。我们假设HIV+PI在休息和运动时比HIVnoPI和Ctrl具有更高的脂解率和更低的FFA氧化率,并且FFA动力学与心脏功能异常相关。方法.在休息和70分钟次极量运动(50% peakVO 2)期间输注1- 13 C棕榈酸酯,以量化3组中的基础和运动刺激的脂解率(PalmRa)和棕榈酸氧化率(PalmOx):HIV+PI(n=10),HIVnoPI(n=9)和Ctrl(n=5)。静息二维和多普勒超声心动图被用来量化心脏收缩和解剖参数。结果:与我们的假设相反,在休息和运动期间,3组之间的PalmRa相似。HIV+PI组静息PalmOx(1.0 <$0.5,p<0.05)高于对照组(0.4 <$0.1),但对照组和HIV无PI组之间无差异(0.8 <$0.4 mmol/kgFFM/min)。当合并HIV+组时,静息(0.9 <$0.4 vs. 0.4 <$0.1)和运动(2.0 <$0.9 vs. 0.8 <$0.4 mmol/kgFFM/min,p<0.03)期间的PalmOx高于对照组。HIV阳性受试者舒张早期血流速度较低(整体em:12.0 <$4.0 vs. 16.4 <$3.8 m/s,p<0.02)和舒张早期峰值(E)与舒张晚期峰值(A)流速比(E/A比:1.4 <$0.4 vs. 2.1 <$0.5,p<0.001),而左心室质量指数(LVMI)倾向于大于对照组(97.1 <$14.4 vs. 86.1 <$6.2 g/m2,p<0.09)。运动时PalmOx与LVMI相关(r=0.46,p<0.05)。血清高密度脂蛋白(HDL)水平与总体emc呈正相关,(r=0.58,p<0.003),射血分数(r=0.37,p<0.08),血流传播(r=0.56,p<0.006),E E/A(r =0.55,p<0.006)与平均动脉压(r=-0.49,p<0.02)、舒张压(r =-0.49,p<0.02)呈负相关。结论:HIV感染与PI使用无关,与休息和运动期间全身FFA氧化率升高相关。 FFA氧化水平升高和血清HDL水平降低预示着心脏功能,特别是舒张功能下降。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TODD CADE其他文献

TODD CADE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TODD CADE', 18)}}的其他基金

FOCUS ISSUE ON HIV AND THE CARDIOMETABOLIC SYNDROME
关注艾滋病毒和心脏代谢综合征
  • 批准号:
    8168733
  • 财政年份:
    2010
  • 资助金额:
    $ 0.98万
  • 项目类别:
POST-EXERCISE HEART RATE RECOVERY IN HIV-POSITIVE INDIVIDUALS ON HIGHLY ACTIVE
HIV 阳性个体进行高强度运动后心率恢复情况
  • 批准号:
    8168797
  • 财政年份:
    2010
  • 资助金额:
    $ 0.98万
  • 项目类别:
FOCUS ISSUE ON HIV AND THE CARDIOMETABOLIC SYNDROME
关注艾滋病毒和心脏代谢综合征
  • 批准号:
    7953968
  • 财政年份:
    2009
  • 资助金额:
    $ 0.98万
  • 项目类别:
BLUNTED LIPOLYSIS AND FATTY ACID OXIDATION DURING MODERATE EXERCISE IN HIV
HIV 患者适度运动期间脂肪分解和脂肪酸氧化减弱
  • 批准号:
    7953980
  • 财政年份:
    2009
  • 资助金额:
    $ 0.98万
  • 项目类别:
FOCUS ISSUE ON HIV AND THE CARDIOMETABOLIC SYNDROME
关注艾滋病毒和心脏代谢综合征
  • 批准号:
    7721563
  • 财政年份:
    2008
  • 资助金额:
    $ 0.98万
  • 项目类别:
METABOLIC AND MOLECULAR ASPECTS OF SARCOPENIA
肌肉减少症的代谢和分子方面
  • 批准号:
    7721465
  • 财政年份:
    2008
  • 资助金额:
    $ 0.98万
  • 项目类别:
DIASTOLIC FUNCTION ASSOC W/ WHOLE-BODY PALMITATE OXIDATION, SERUM HDL IN HIV+
HIV 中的舒张功能关联与全身棕榈酸氧化、血清 HDL
  • 批准号:
    7355268
  • 财政年份:
    2006
  • 资助金额:
    $ 0.98万
  • 项目类别:
METABOLIC AND MOLECULAR ASPECTS OF SARCOPENIA
肌肉减少症的代谢和分子方面
  • 批准号:
    7355277
  • 财政年份:
    2006
  • 资助金额:
    $ 0.98万
  • 项目类别:
LIPID KINETICS DURING ACUTE EXERCISE IN HIV
HIV 急性运动期间的脂质动力学
  • 批准号:
    7180192
  • 财政年份:
    2005
  • 资助金额:
    $ 0.98万
  • 项目类别:
LIPID METABOLISM DURING ACUTE EXERCISE IN HIV
HIV 急性运动期间的脂质代谢
  • 批准号:
    6971985
  • 财政年份:
    2004
  • 资助金额:
    $ 0.98万
  • 项目类别:

相似海外基金

Examining the Function of a Novel Protein in the Cardiac Junctional Membrane Complex
检查心脏连接膜复合体中新型蛋白质的功能
  • 批准号:
    10749672
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
  • 批准号:
    MR/Y003594/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Research Grant
Towards widespread use of cardiac MRI using new affordable low magnetic field (0.55T) MRI scanner and AI
使用新型经济实惠的低磁场 (0.55T) MRI 扫描仪和 AI 实现心脏 MRI 的广泛使用
  • 批准号:
    2904562
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Studentship
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac Surgery
使用新颖的机器学习方法制定个性化策略,预防心脏手术后持续性 AKI
  • 批准号:
    10979324
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
Novel minimally-invasive in-situ 3D bioprinting platform for cardiac regeneration
用于心脏再生的新型微创原位3D生物打印平台
  • 批准号:
    EP/X027287/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Fellowship
Investigating the mechanosensitive interplays between genetic control and self-organisation during the emergence of cardiac tissue curvature
研究心脏组织曲率出现过程中遗传控制和自组织之间的机械敏感性相互作用
  • 批准号:
    BB/Y00566X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Research Grant
Prevention of Infections in Cardiac Surgery (PICS): a cluster-randomized factorial cross-over trial
心脏手术中感染的预防 (PICS):整群随机因子交叉试验
  • 批准号:
    498291
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Operating Grants
Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
  • 批准号:
    23H03001
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for cardiac fibrosis using a cell removal vaccine
使用细胞去除疫苗开发治疗心脏纤维化的新疗法
  • 批准号:
    23K07504
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
  • 批准号:
    23K07526
  • 财政年份:
    2023
  • 资助金额:
    $ 0.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了